Table 2.

Summary of mouse tissue used for immunohistochemical analysis of novel antibodies

Mouse line	Treatment	Fixative	References
M83+/−	Intramuscular injection of αS fibrils (motor impaired/terminal)	150 mM NaCl/ 70 % ethanol	[28]
M83+/−	Intramuscular injection of αS fibrils (motor impaired/terminal)	Formalin	[28]
M83+/−	Cerebral injection of αS fibrils (3 months post-injection)	150 mM NaCl/ 70 % ethanol	[26]
M83+/+	Naïve (7 month old; no phenotype)	150 mM NaCl/ 70 % ethanol
M83+/+	Naïve (10–12 month old; motor impaired/terminal)	150 mM NaCl/ 70 % ethanol
M20+/−	Cerebral injection of αS fibrils (4 months post-injection)	150 mM NaCl/ 70 % ethanol	[27]
M20+/−	Cerebral injection of αS fibrils (4 months post-injection)	Formalin	[27]
WT	Naïve	150 mM NaCl/ 70 % ethanol